Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
Open Access
- 15 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 48 (4), 484-488
- https://doi.org/10.1086/596482
Abstract
Once-daily regimens of antiretroviral therapy are simpler than other regimens, but whether such regimens are associated with better adherence to treaKeywords
This publication has 24 references indexed in Scilit:
- Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral SuppressionHIV Research & Clinical Practice, 2008
- Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceAIDS, 2008
- Adherence with lopinavir/ritonavir (LPV/r) tablet and SoftGel (SGC) capsule based antiretroviral regimens and predictors of early treatment complianceJournal of the International AIDS Society, 2008
- A Lopinavir/Ritonavir-Based Once-Daily Regimen Results in Better Compliance and Is Non-inferior to a Twice-Daily Regimen Through 96 WeeksAIDS Research and Human Retroviruses, 2007
- Pillbox Organizers are Associated with Improved Adherence to HIV Antiretroviral Therapy and Viral Suppression: a Marginal Structural Model AnalysisClinical Infectious Diseases, 2007
- Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled studyAIDS, 2007
- Pilot Study of Once-Daily Simplification Therapy with Abacavir/Lamivudine/Zidovudine and Efavirenz for Treatment of HIV-1 InfectionHIV Research & Clinical Practice, 2006
- Durability of Adherence to Antiretroviral Therapy on Initial and Subsequent RegimensAIDS Patient Care and STDs, 2006
- Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral TherapyClinical Infectious Diseases, 2004
- Once‐Daily versus Twice‐Daily Lopinavir/Ritonavir in Antiretroviral‐Naive HIV‐Positive Patients: A 48‐Week Randomized Clinical TrialThe Journal of Infectious Diseases, 2004